A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: The interferon‐inducible gene IFI16
Michele Mondini(Inserm), Santo Landolfo(University of Turin), Emanuele Albano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Pier Luigi Meroni(IRCCS Istituto Auxologico Italiano), Paolo Airó(University of Lisbon), Piersandro Riboldi(University of Milan), Roberta D’Ambrosio(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Barbara Azzimonti(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Matteo Vidali(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Yehuda Shoenfeld(Tel Aviv University), Marisa Gariglio(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Marco De Andrea(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”)
Cited by 73
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
|Hepatology|2012|404
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|392
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
|Journal of Hepatology|2020|361
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
|Annals of the Rheumatic Diseases|2016|355